Download PDF
Exp Clin Endocrinol Diabetes 2023; 131(01/02): 61-65
DOI: 10.1055/a-1946-3783
German Diabetes Association: Clinical Practice Guidelines

Nephropathy in Diabetes

Authors

  • Ludwig Merker

    1   Diabetologie im MVZ am Park Ville d’Eu, Haan, Germany

  • Thomas Ebert

    2   Department of Endocrinology, Nephrology and Rheumatology, University Hospital Leipzig, Leipzig, Germany

  • Martina Guthoff

    3   Department of Diabetology, Endocrinology, Nephrology, University Hospital Tübingen, Tübingen, Germany

  • Berend Isermann

    4   Institute for Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig, Leipzig, Germany
Further Information
Also available at
  Permissions and Reprints
Preview
Notice of update

The DDG practice recommendations are updated regularly during the second half of the calendar year. Please ensure that you read and cite the respective current version.

Updates To Content And Different Recommendations Compared To The Previous Year’s Version

Recommendation 1: Additional information added to the general measures

Reason: Important measures for the self-management of CKD

Supporting reference: [11]

Recommendation 2: Blood pressure target value lowered

Reason: Current guideline recommendation

Supporting reference: [12]

Recommendation 3: Use of non-steroidal mineralocorticoid receptor antagonists in future

Reason: New data from endpoint studies

Supporting reference: [13] [14]

Recommendation 4: Use of some SGLT-2 inhibitors also in stage G4

Reason: Newer data

Supporting reference: [11]



Publication History

Article published online:
23 January 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany